Carrier capable of inhibiting tumor multidrug resistance and preparation method thereof
A multi-drug resistance and carrier technology, which is applied in the direction of anti-tumor drugs, pharmaceutical formulations, drug combinations, etc., can solve problems such as inability to effectively overcome tumor multi-drug resistance, and achieve the effect of accelerating drug release
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] A carrier for inhibiting tumor multidrug resistance, the carrier is a targeting molecule-polyethylene glycol-pyrene amphiphilic polymer, wherein the targeting molecule is biotin as an example, and the specific molecular formula is as follows:
[0027]
[0028] where n=45.
[0029] The preparation method of the above-mentioned anti-tumor multi-drug resistance carrier comprises the following steps:
[0030] (1) Preparation of double-terminal carboxylated PEG 2000
[0031] Mix PEG 2000 and 3,3-dithiodipropionic acid at a molar ratio of 1:2, and react at 25°C for 24 hours to obtain double-terminal carboxylated PEG 2000;
[0032] (2) Preparation of biotin-PEG 2000
[0033] Mix biotin with the double-terminal carboxylated PEG 2000 obtained in step (1) at a molar ratio of 1:1, and conduct condensation reaction at 25°C for 24 hours to obtain biotin-PEG 2000;
[0034] (3) Preparation of biotin-PEG-pyrene amphiphilic polymer carrier
[0035] Mix biotin-PEG 2000 obtained in...
Embodiment 2
[0041] A carrier for inhibiting tumor multidrug resistance, the carrier is a targeting molecule-polyethylene glycol-pyrene amphiphilic polymer, wherein the targeting molecule is biotin as an example, and the specific molecular formula is as follows:
[0042]
[0043] where n=23.
[0044] The preparation method of the above-mentioned anti-tumor multi-drug resistance carrier comprises the following steps:
[0045] (1) Preparation of double-terminal carboxylated PEG 1000
[0046] Mix PEG 1000 and 3,3-dithiodipropionic acid at a molar ratio of 1:2, and react at 40°C for 16 hours to prepare double-terminal carboxylated PEG 1000;
[0047] (2) Preparation of biotin-PEG 1000
[0048] Mix biotin with the double-terminal carboxylated PEG 1000 obtained in step (1) at a molar ratio of 1:1, and carry out condensation reaction at 40°C for 16 hours to obtain biotin-PEG 1000;
[0049] (3) Preparation of biotin-PEG-pyrene amphiphilic polymer carrier
[0050] Mix the biotin-PEG 1000 obta...
Embodiment 3
[0056] A carrier for inhibiting tumor multidrug resistance, the carrier is a targeting molecule-polyethylene glycol-pyrene amphiphilic polymer, wherein the targeting molecule is biotin as an example, and the specific molecular formula is as follows:
[0057]
[0058] where n=17.
[0059] The preparation method of the above-mentioned anti-tumor multi-drug resistance carrier comprises the following steps:
[0060] (1) Preparation of double-terminal carboxylated PEG 750
[0061] Mix PEG 750 and 3,3-dithiodipropionic acid at a molar ratio of 1:4, and react at 40°C for 16 hours to prepare double-terminal carboxylated PEG 750;
[0062] (2) Preparation of biotin-PEG 750
[0063] Mix biotin with the double-terminal carboxylated PEG 750 obtained in step (1) at a molar ratio of 1:1, and conduct condensation reaction at 35°C for 20 hours to obtain biotin-PEG 750;
[0064] (3) Preparation of biotin-PEG-pyrene amphiphilic polymer carrier
[0065] Mix the biotin-PEG 750 obtained in s...
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com